Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs > Nektar Therapeutics (NKTR)

Bad link... try this one for AMLN [#msg-10433899]

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SeriousMoney Member Profile
 
Followed By 30
Posts 7,965
Boards Moderated 5
Alias Born 04/05/05
160x600 placeholder
Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemoph... "PR Newswire (US)" - 8/21/2014 3:33:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/1/2014 6:06:29 AM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 8/1/2014 6:04:31 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/31/2014 4:35:28 PM
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 "PR Newswire (US)" - 7/31/2014 4:10:00 PM
Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financ... "PR Newswire (US)" - 7/22/2014 6:46:00 PM
Data Published in the New England Journal of Medicine Demonstrate that Naloxegol Improved Opioid-Induced Constipation in Chro... "PR Newswire (US)" - 6/19/2014 3:29:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/18/2014 8:01:08 AM
US FDA ADVISORY COMMITTEE RECOMMENDS NO CARDIOVASCULAR OUTCOMES TRIAL FOR PERIPHERALLY-ACTING MU-OPIOID RECEPTOR ANTAGONIST (... "PR Newswire (US)" - 6/12/2014 4:15:00 PM
Nektar Therapeutics Stock Trading Halted Today; FDA Advisory Committee to Discuss Peripherally-Acting Opioid Receptor Antagon... "PR Newswire (US)" - 6/11/2014 7:05:00 AM
Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, at 50th ASCO Meeting "PR Newswire (US)" - 6/1/2014 9:00:00 AM
Positive Data from Phase 2 Trial of NKTR-102 in Patients with AvastinĀ®-Refractory High-Grade Glioma Presented at 50th ASCO M... "PR Newswire (US)" - 5/31/2014 2:15:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/19/2014 5:51:46 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 5/19/2014 5:17:36 PM
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer "PR Newswire (US)" - 5/19/2014 8:00:00 AM
Nektar Therapeutics To Present at the UBS 2014 Global Healthcare Conference in New York City "PR Newswire (US)" - 5/16/2014 10:22:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/8/2014 6:03:08 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/7/2014 4:29:41 PM
Nektar Therapeutics Reports Financial Results for the First Quarter of 2014 "PR Newswire (US)" - 5/7/2014 4:15:00 PM
Nektar to Announce Financial Results for the First Quarter 2014 on Wednesday, May 7, 2014, After Close of U.S.-Based Financia... "PR Newswire (US)" - 5/1/2014 4:10:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/15/2014 4:25:59 PM
Watch List for Equities Hitting New High -- Research on Nektar Therapeutics, Clean Diesel Technologies, MeetMe, and Bazaarvoice "PR Newswire (US)" - 4/10/2014 1:06:00 PM
Nektar Reports Positive Preclinical Data for Two Oncology Programs at 2014 AACR "PR Newswire (US)" - 4/9/2014 9:00:00 AM
Nektar Rises on FDA Notification (revised) - Analyst Blog "Zacks" - 3/27/2014 2:50:01 PM
Patient Support Programs, Financial Results, and Stock Price Movements - Analyst Notes on Gilead, Forest Laboratories, Thermo... "PR Newswire (US)" - 3/6/2014 8:25:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist